Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

Area of Science:

• Cardiovascular Medicine
• Immunology
• Inflammation Research

Background:

• Atherosclerosis underlies major cardiovascular events like myocardial infarction and stroke.
• Current statin therapies are insufficient for complete prevention of clinical events.
• Emerging research highlights the inflammatory basis of atherosclerosis pathogenesis.

Purpose of the Study:

• To review novel therapeutic targets in atherosclerosis based on its inflammatory nature.
• To explore the potential of anti-inflammatory treatments and immunomodulation in cardiovascular disease.
• To discuss emerging strategies such as cytokine blockade, T-cell expansion, and active immunization.

Main Methods:

• Review of recent genetic and epidemiological data linking chronic inflammatory diseases and atherosclerosis.
• Analysis of anti-inflammatory treatment regimens (e.g., TNF-alpha blockade, IL-1 antagonism) for potential cardiovascular benefits.
• Evaluation of immunotherapeutic strategies, including regulatory T-cell expansion and atherosclerosis-related antigen immunization.

Main Results:

• Shared pathologies exist between chronic inflammatory conditions and atherosclerosis.
• Anti-inflammatory treatments used in other diseases may benefit patients with coronary artery disease.
• Immunization strategies against LDL antigens show promise in preclinical models.

Conclusions:

• Targeting inflammation offers a promising approach to prevent cardiovascular events.
• Future therapies may involve enhancing atheroprotective immunity and active immunization.
• Successful implementation requires precise patient selection and appropriate clinical endpoints.